欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0186/001
药品名称Ceftazidime Kabi
活性成分
    • ceftazidime 500.0 mg
剂型Powder for solution for injection
上市许可持有人Fresenius Kabi Pharma Portugal, Lda. Av. do Forte, 3 - Edifício Suécia I - Piso 2 Carnaxide
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Iceland (IS)
    • Hungary (HU)
    • Spain (ES)
    • Greece (GR)
    • Finland (FI)
    • Slovenia (SI)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Ceftazidim Kabi 0,5 g Pulver zur Herstellung einer Injektionslösung
    • Norway (NO)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      CEFTAZIDIME FRESENIUS KABI 500MG
许可日期2008/10/22
最近更新日期2023/12/13
药物ATC编码
    • J01DD02 ceftazidime
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase